Entera Bio Ltd. Annual Deferred Income Tax Expense (Benefit) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Entera Bio Ltd. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from 2020 to 2023.
  • Entera Bio Ltd. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000.
  • Entera Bio Ltd. annual Deferred Income Tax Expense (Benefit) for 2023 was $29K, a 83.3% decline from 2022.
  • Entera Bio Ltd. annual Deferred Income Tax Expense (Benefit) for 2022 was $174K.
  • Entera Bio Ltd. annual Deferred Income Tax Expense (Benefit) for 2021 was -$217K.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.